More about

Autoimmune Disease

News
September 12, 2020
3 min read
Save

Cognitive dysfunction ‘common yet underrecognized’ in rheumatic disease

Cognitive dysfunction ‘common yet underrecognized’ in rheumatic disease

Although a commonly reported complication, cognitive dysfunction associated with rheumatic disease is often “shrouded in this cloud of mystery” for rheumatologists, a presenter said at the 2020 Congress of Clinical Rheumatology-East.

News
August 25, 2020
2 min read
Save

Risk for COVID-19 varies by rheumatic disease, age, prior therapy use

Risk for COVID-19 varies by rheumatic disease, age, prior therapy use

The risk for hospital-diagnosed COVID-19 among patients with autoimmune or immune-mediated disease may depend on age, specific disease and prior therapy, according to data published in the Annals of the Rheumatic Diseases.

News
August 13, 2020
4 min read
Save

Some dry eye may have a systemic cause

Some dry eye may have a systemic cause

Your patient is back — again. She has presented with red, dry eyes for the last 2 years.

News
August 03, 2020
2 min read
Save

Upadacitinib superior to methotrexate in treating rheumatoid arthritis

Upadacitinib superior to methotrexate in treating rheumatoid arthritis

Upadacitinib monotherapy, at 15 or 30 mg daily, significantly improves clinical, radiographic and patient-reported outcomes in rheumatoid arthritis, compared with weekly methotrexate, according to data published in Arthritis & Rheumatology.

News
July 22, 2020
2 min read
Save

Autoimmune disease more prevalent in patients with juvenile arthritis vs. ADHD

Autoimmune disease more prevalent in patients with juvenile arthritis vs. ADHD

Patients with juvenile idiopathic arthritis are more likely to develop concurrent autoimmune disease than those with attention deficit hyperactivity disorder, according to data published in Pediatric Rheumatology.

News
July 17, 2020
1 min read
Save

Establishing EGPA Diagnosis and Prognosis

Learning Objectives:

News
July 12, 2020
2 min read
Save

JAK inhibitors offer safe, effective ‘patient-centric approach’ to broad range of IMIDs

JAK inhibitors offer safe, effective ‘patient-centric approach’ to broad range of IMIDs

While FDA- and EU-approved JAK inhibitors have shown comparable efficacy and safety across a spectrum of immune-mediated diseases, more study is required to fully parse the mechanism of action, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.

News
July 02, 2020
2 min read
Save

Appeals court upholds Amgen victory in Enbrel fight; Sandoz eyes Supreme Court

Appeals court upholds Amgen victory in Enbrel fight; Sandoz eyes Supreme Court

A U.S. appeals court has ruled in favor of two patents for Amgen’s etanercept against the biosimilar etanercept-szzs from Novartis’ Sandoz, upholding a prior decision validating claims of patent infringement.

News
June 16, 2020
2 min read
Save

Primary humoral immunodeficiencies linked to psychiatric disorders, suicidal behavior

Primary humoral immunodeficiencies linked to psychiatric disorders, suicidal behavior

Primary humoral immunodeficiencies appeared significantly associated with psychiatric disorders and suicidal behavior, according to study results published in JAMA Psychiatry.

News
June 09, 2020
1 min read
Save

Kymera to study role of IRAK4 in hidradenitis suppurativa, atopic dermatitis

Kymera Therapeutics has initiated a non-interventional trial evaluating IRAK4 expression in hidradenitis suppurativa and atopic dermatitis, according to a press release.

View more